• Opinion
• [Reporter's View] Pharmas rethink bio venture investments
• by Lee, Seok-Jun Jul 30, 2024 05:51am

• Opinion
• [Reporter's View] Keeping up with the Chinese bio industry
• by Son, Hyung-Min Jul 24, 2024 05:51am

• Opinion
• [Reporter’s View] ‘Cool time’ too short for price cuts
• by Kim, Jin-Gu Jul 19, 2024 05:47am

• Opinion
• [Reporter’s view] public-private consultative body
• by Lee, Jeong-Hwan Jul 17, 2024 05:50am

• Opinion
• [Reporter's View] Aspirations for Indication-based pricing
• by Eo, Yun-Ho Jul 17, 2024 05:50am

• Opinion
• [Desk’s View] Respect Korea's generic drug industry
• by Lee, Tak-Sun Jul 16, 2024 05:46am

• Opinion
• [Reporter’s View] MFDS provides support for drug shortages
• by Lee, Hye-Kyung Jul 15, 2024 05:47am

• Opinion
• [Reporter’s View] 'all-comers' with strict criteria
• by Eo, Yun-Ho Jul 2, 2024 05:48am

• Opinion
• [Reporter’s View] No innovation without failure
• by Son, Hyung-Min Jul 1, 2024 05:47am

• Opinion
• [Reporter's View] No more exemptions, just deferrals
• by Eo, Yun-Ho Jun 24, 2024 05:47am